537 results on '"Wilcox, M. H."'
Search Results
2. A Five Year Outbreak of Methicillin-Susceptible Staphylococcus aureus Phage Type 53,85 in a Regional Neonatal Unit
3. Clostridium difficile Infection
4. Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012
5. Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)?
6. Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening
7. Controlling Clostridium difficile Infection and the Role of Antibiotic Stewardship
8. Supplement to: Bezlotoxumab for prevention of Clostridium difficile infection recurrence.
9. SHORT REPORT: Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010–2012
10. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)
11. Reply to Walk et al
12. Changing Epidemiology of Clostridium difficile Infection Following the Introduction of a National Ribotyping-Based Surveillance Scheme in England
13. Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile
14. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
15. Coagulase-Negative Staphylococci: Adherence and Slime Production
16. Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model
17. In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile
18. SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model
19. Toxin Production, Adherence and Protein Expression by Clinical Aeromonas spp. Isolates in Broth and Human Pooled Ileostomy Fluid
20. Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection
21. In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection
22. Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure
23. Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010–2012
24. Protecting the Microbiota
25. Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery
26. Controlling Clostridium difficile Infection and the Role of Antibiotic Stewardship
27. DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. (Original Article)
28. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection
29. Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model
30. O2 Who should have gonorrhoea cultures in addition to gonorrhoea and chlamydia nucleic acid amplification tests? Cost effectiveness study
31. Clostridium difficile whole genome sequences from patients in Leeds and Oxfordshire demonstrate substantial geographical segregation of clinical strains: O668
32. Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model
33. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI)
34. First results of the European Clostridium difficile infection survey (ECDIS): O86
35. A case–control study of community-associated Clostridium difficile infection
36. Infection control measures to limit the spread of Clostridium difficile
37. Evidence for low risk of Clostridium difficile infection associated with tigecycline
38. Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice
39. Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients
40. The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces
41. Prevention of Clostridium difficile infection at the bedside
42. Laboratory diagnosis of Clostridium perfringens antibiotic-associated diarrhoea
43. Evidence for antibiotic induced Clostridium perfringens diarrhoea
44. Respiratory antibiotic use and Clostridium difficile infection: is it the drugs or is it the doctors?
45. Diagnosis of central venous catheter related sepsis-a critical look inside
46. Investigating the transient and persistent effects of heat on Clostridium difficile spores
47. Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon
48. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam
49. Mycobacterium avium-intracellulare complex causing penile ulceration in an immunocompetent man
50. Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.